---
layout: post
title: "港股生物医药板块下挫 再鼎医药(09688.HK)跌超17%"
date: 2022-03-04 09:41:56 +0800
categories: hafuzixun
tags: 哈富资讯新闻
---
<p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.09688" data-code="09688|116|5" data-code2="09688|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.09688&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 09688_0" data-code="K 09688|116|5" data-code2="K 09688|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>港股生物医药板块下挫，再鼎医药(09688.HK)跌超17%，和黄医药(00013.HK)跌近14%，百济神州(06160.HK)跌超12%，腾盛博药(02137.HK)跌近6%，药明生物(02269.HK)跌超5%，康方生物跌近5%。<br /></p><p class="em_media">（文章来源：哈富资讯）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203042296715483>

[返回哈富资讯新闻](//finews.withounder.com/category/hafuzixun.html)｜[返回首页](//finews.withounder.com/)